已收盘 09-19 16:00:00 美东时间
-0.280
-0.87%
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
09-16 09:48
Across the recent three months, 7 analysts have shared their insights on VICI P...
09-16 04:01
Major U.S. equity benchmarks remain perched near record highs as investors brace for next week’s Federal Open Market Committee policy decision—a potential catalyst for heightened volatility across mar...
09-13 00:39
今日重点评级关注:HC Wainwright & Co.:维持Microbot Medical"买入"评级,目标价从9美元升至12美元;Maxim Group:维持Neuphoria Therapeutics"买入"评级,目标价从18美元升至35美元
09-12 12:53
Mizuho analyst Haendel St. Juste maintains VICI Properties (NYSE:VICI) with a Outperform and raises the price target from $34 to $35.
09-11 21:24
今日重点评级关注:瑞银:上调Gossamer Bio评级至"买入",目标价从1.25美元升至9美元;Canaccord Genuity:维持Corcept Therapeutics"买入"评级,目标价从137美元升至140美元
09-11 10:06
This week's dividend activity included increased payouts from Philips Edison (PECO) and VICI Properties (VICI) as well as declarations from companies such as Salesforce (NYSE:CRM) and Walmart (NYSE:WM...
09-05 21:31
VICI Properties Inc. (NYSE:VICI) ("VICI Properties") announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.45 per share of common stock for the period from July 1, 2025 to
09-04 20:12
今日重点评级关注:摩根大通:维持Futu Holdings"超配"评级,目标价从200美元升至270美元;Craig-Hallum:维持英伟达"买入"评级,目标价从195美元升至245美元
08-29 09:47
Across the recent three months, 4 analysts have shared their insights on VICI P...
08-29 02:01